Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Assets: 2016-2024

Historic Non-Current Assets for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $211.9 million.

  • Organogenesis Holdings' Non-Current Assets rose 1.10% to $210.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $210.1 million, marking a year-over-year increase of 1.10%. This contributed to the annual value of $211.9 million for FY2024, which is 9.80% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Non-Current Assets of $211.9 million as of FY2024, which was down 9.80% from $235.0 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Non-Current Assets registered a high of $235.0 million during FY2023, and its lowest value of $115.9 million during FY2020.
  • Moreover, its 3-year median value for Non-Current Assets was $226.8 million (2022), whereas its average is $224.6 million.
  • In the last 5 years, Organogenesis Holdings' Non-Current Assets soared by 86.65% in 2021 and then fell by 9.80% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Non-Current Assets (Yearly) stood at $115.9 million in 2020, then surged by 86.65% to $216.3 million in 2021, then grew by 4.84% to $226.8 million in 2022, then grew by 3.63% to $235.0 million in 2023, then dropped by 9.80% to $211.9 million in 2024.